Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

ABSTRACT:

SUBMITTER: Wang W 

PROVIDER: S-EPMC11178534 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature